#hormone-replacement-therapy

#hormone-replacement-therapy

On Monday, the FDA announced that hormone replacement therapy (HRT) products will no longer carry black box warnings stating they cause increased risk of breast cancer, heart attack, and stroke. The label was added to these products in the early 2000s following the publication of the Women's Health Initiative study, the results of which experts say were misinterpreted. The FDA's announcement states that the study "found a statistically nonsignificant increase in the risk of breast cancer diagnosis.

Women with type 2 diabetes should consider switching their HRT tablets to patches to reduce their risk of potentially fatal blood clots, according to a new study. Researchers have found women with the condition who take an oral form of HRT have double the risk of a pulmonary embolism - when a blood clot blocks an artery in the lung - than those using skin patches. They also have a 21 per cent increased risk of heart disease, the study revealed.

I'm proud to have passed my bill A2698 directing DOH to create an awareness campaign regarding the usage of hormone replacement therapy for treating menopause and perimenopause. Too many people, especially Black, working-class, and immigrant women, go without the care they need simply because they don't know what's available or because providers don't take their symptoms seriously. As a maternal health nurse, I believe every stage of reproductive life deserves real support. Menopause is no exception.